2009

New Bioequivalent Option is now available for Effexor XR®
May 19, 2009

2008

Regence’s coverage policy developed to encourage generic alendronate (Fosamax®) is an excellent opportunity to reduce patients’ copayments
August 14, 2008

Important Information about Generic OxyContin®
June 13, 2008

MDeNews™ June 2008
Avastin® Approved for use in Metastatic Breast Cancer – The Controversial FDA Decision
June 2008

NHLBI Guidelines and clinical studies suggest that Advair® and Symbicort® should be reserved for patients not adequately controlled on ICS products
May 30, 2008

Actavis Totowa LLC announced the voluntary recall of Digitek® (digoxin) for all tablets under both the “Bertek” and “UDL” label
May 7, 2008

MDeNews™ January 2008
Erythropoetin Stimulating Agents and Chemotherapy Induced Anemia - Emerging Safety Concerns
January 2008

RxNews Archive